Prevalence of Adrenal Insufficiency in Clinically Stable Adults Living with HIV Attending Outpatient Clinics in Malaysia

Authors

  • Qing Ci Goh Hospital Melaka, Malaysia https://orcid.org/0000-0003-3144-423X
  • Subashini Rajoo Hospital Kuala Lumpur, Malaysia
  • Norlaila Mustafa Hospital Canselor Tuanku Muhriz University Kebangsaan Malaysia
  • Chin Voon Tong Hospital Melaka, Malaysia

DOI:

https://doi.org/10.15605/jafes.041.02.6383

Keywords:

adrenal insufficiency, adrenal cortex antibodies, HIV infections, adrenocorticotropic hormone, highly active antiretroviral therapy

Abstract

Background. Adrenal insufficiency (AI) is a potentially life-threatening condition in people living with HIV/AIDS. Data on this topic are scarce and estimates of its prevalence vary.

Objective. To determine the prevalence of AI among people living with HIV and to guide the management strategies.

Methodology. This is a cross-sectional study conducted at the Infectious Diseases Clinics of two tertiary centres. Clinical and laboratory data were collected, and Synacthen (cosyntropin) stimulation tests were performed. Adrenal antibodies and Adrenocorticotropic Hormone (ACTH) levels were analysed in those who had an inadequate Synacthen response. The data were analysed using SPSS (version 28.0).

Result. A total of 110 stable outpatient adults living with HIV, aged 18 to 80 years, were recruited. The mean age of the studied population was 37.5 ± 10.6 years, 81.8% were male, 23.6% had a normal BMI and 64.5% were either overweight or obese. The median disease duration was 4.5 years and all subjects had been on HAART for a median duration of 3.8 years. Treatment failure occurred in 20% of participants, 41.8% had a history of opportunistic infections and 4.5% had autoimmune diseases. The mean nadir CD4 count was 202 cells/mm³ ± 200 with 60.6% below 200 cells/mm³. At the time of the Synacthen tests, 88.2% had a viral load of <40 copies/ml while 89.1% had a CD4 count >200 cells/mm³. AI was identified in 2 participants (1.8%; 95% CI 0.2-6.4%). Their adrenal antibodies were negative, and ACTH levels were 4.5 ± 5.9 pmol/L. Both had significantly lower nadir CD4 counts (p <0.001), a history of treatment failure (p = 0.039) and symptoms suggestive of AI (p = 0.004).

Conclusion. This study revealed a low prevalence of AI (1.8%) among stable HIV patients on HAART. Significant associations with AI were found in participants with lower nadir CD4 counts, a history of treatment failure, and symptoms suggestive of AI.

Downloads

Download data is not yet available.

Author Biographies

Qing Ci Goh, Hospital Melaka, Malaysia

Endocrinology Unit, Department of Medicine, Hospital Melaka, Malaysia

Subashini Rajoo, Hospital Kuala Lumpur, Malaysia

Endocrinology Unit, Department of Medicine, Hospital Kuala Lumpur, Malaysia

Norlaila Mustafa, Hospital Canselor Tuanku Muhriz University Kebangsaan Malaysia

Endocrinology Unit, Department of Medicine, Hospital Canselor Tuanku Muhriz University Kebangsaan Malaysia

Chin Voon Tong, Hospital Melaka, Malaysia

Endocrinology Unit, Department of Medicine, Hospital Melaka, Malaysia

References

1. Yen YF, Chuang PH, Jen IA, et al. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000-2012. Ann Rheum Dis. 2017;76(4):661-5. https://pubmed.ncbi.nlm.nih.gov/27590658 https://doi.org/10.1136/annrheumdis-2016-209815

2. Massabki PS, Accetturi C, Nishie IA, da Silva NP, Andrade LE. Clinical implications of autoantibodies in HIV infection. AIDS. 1997;11(15):1845-50. https://pubmed.ncbi.nlm.nih.gov/9412703 https://doi.org/10.1097/00002030-199715000-00009

3. Naletto L, Frigo AC, Ceccato F, et al. The natural history of autoimmune Addison's disease from the detection of autoantibodies to development of the disease: a long-term follow-up study on 143 patients. Eur J Endocrinol. 2019;180(3):223-34. https://pubmed.ncbi.nlm.nih.gov/30608902 https://doi.org/10.1530/EJE-18-0313

4. Bricaire F, Marche C, Zoubi D, Regnier B, Saimot AG. Adrenocortical lesions and AIDS. Lancet. 1988;1(8590):881. https://pubmed.ncbi.nlm.nih.gov/2895383 https://doi.org/10.1016/s0140-6736(88)91624-8

5. Nassoro DD, Mkhoi ML, Sabi I, Meremo AJ, Lawala PS, Mwakyula IH. Adrenal insufficiency: A forgotten diagnosis in HIV/AIDS patients in developing countries. Int J Endocrinol. 2019;2019:2342857. https://pubmed.ncbi.nlm.nih.gov/31341472 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612386 https://doi.org/10.1155/2019/2342857

6. Afreen B, Khan KA, Riaz A. Adrenal insufficiency in Pakistani HIV-infected patients. J Ayub Med Coll Abbottabad. 2017;29(3):428-31. https://pubmed.ncbi.nlm.nih.gov/29076676

7. Raffi F, Brisseau JM, Planchon B, Rémi JP, Barrier JH, Grolleau JY. Endocrine function in 98 HIV-infected patients: A prospective study. AIDS. 1991;5(6):729-33. https://pubmed.ncbi.nlm.nih.gov/1883545 https://doi.org/10.1097/00002030-199106000-00013

8. Sharma N, Sharma LK, Anand A, et al. Presence, patterns & predictors of hypocortisolism in patients with HIV infection in India. Indian J Med Res. 2018;147(2):142-50. https://pubmed.ncbi.nlm.nih.gov/29806602 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991125 https://doi.org/10.4103/ijmr.IJMR_43_16

9. Shashidhar PK, Shashikala GV. Low dose adrenocorticotropic hormone test and adrenal insufficiency in critically ill acquired immunodeficiency syndrome patients. Indian J Endocrinol Metab. 2012;16(3):389-94. https://pubmed.ncbi.nlm.nih.gov/22629505 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354846 https://doi.org/10.4103/2230-8210.95680

10. Piédrola G, Casado JL, López E, Moreno A, Perez-Elías MJ, García-Robles R. Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endocrinol (Oxf). 1996;45(1):97-101. https://pubmed.ncbi.nlm.nih.gov/8796145 https://doi.org/10.1111/j.1365-2265.1996.tb02066.x

11. Hyle EP, Wood BR, Backman ES, et al. High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy. J Acquir Immune Defic Syndr. 2013;63(5):602-8. https://pubmed.ncbi.nlm.nih.gov/23714741 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805773 https://doi.org/10.1097/QAI.0b013e31829b662b

12. Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: Six cases. J Clin Endocrinol Metab. 2005;90(7):4394-8. https://pubmed.ncbi.nlm.nih.gov/15755851 https://doi.org/10.1210/jc.2005-0036

13. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach, 2nd ed. Geneva: World Health Organization; 2016. https://pubmed.ncbi.nlm.nih.gov/27466667 Bookshelf ID: NBK374294

14. Mifsud S, Gauci Z, Gruppetta M, Mallia Azzopardi C, Fava S. Adrenal insufficiency in HIV/AIDS: A review. Expert Rev Endocrinol Metab. 2021;16(6):351-62. https://pubmed.ncbi.nlm.nih.gov/34521306 https://doi.org/10.1080/17446651.2021.1979393

15. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-89. https://pubmed.ncbi.nlm.nih.gov/26760044 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880116 https://doi.org/10.1210/jc.2015-1710

16. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372):1881-93.

17. Regal M, Páramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735-740. https://pubmed.ncbi.nlm.nih.gov/12788587 https://doi.org/10.1016/S0140-6736(03)13492-7

18. Olafsson AS, Sigurjonsdottir HA. Increasing prevalence of Addison disease: Results from a nationwide study. Endocr Pract. 2016;22(1):30-5. https://pubmed.ncbi.nlm.nih.gov/26437215 https://doi.org/10.4158/EP15754.OR

19. Kibirige D, Owarwo N, Kyazze AP, et al. Prevalence, clinical features, and predictors of adrenal insufficiency in adults with tuberculosis or HIV: A systematic review and meta-analysis. Open Forum Infect Dis. 2024;11(4):ofae098. https://pubmed.ncbi.nlm.nih.gov/38560601 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981394 https://doi.org/10.1093/ofid/ofae098

20. UNAIDS. 2023 UNAIDS global AIDS update. Geneva: UNAIDS; 2023.

21. Suleiman A, Chai PT, eds. 2022 Global AIDS monitoring, Country progress report - Malaysia. Ministry of Health Malaysia; 2022.

22. Akbar RZA, Hatta SFWM. Endocrinopathies in HIV infected patients. J Clin Health Sci. 2020;5(2):39-45. https://doi.org/10.24191/jchs.v5i2.8971

23. Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1987;65(3):482-7. PMID: 3040796 https://doi.org/10.1210/jcem-65-3-482

24. Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE. CD4 count as a predictor of adrenocortical insufficiency in persons with human immunodeficiency virus infection: How useful? Indian J Endocrinol Metab. 2013;17(6):1012-7. https://pubmed.ncbi.nlm.nih.gov/24381877 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872678 https://doi.org/10.4103/2230-8210.122615

Downloads

Published

2026-08-28

How to Cite

Goh, Q. C., Rajoo, S., Mustafa, N., & Tong, C. V. (2026). Prevalence of Adrenal Insufficiency in Clinically Stable Adults Living with HIV Attending Outpatient Clinics in Malaysia. Journal of the ASEAN Federation of Endocrine Societies, 41(2). https://doi.org/10.15605/jafes.041.02.6383

Issue

Section

Original Articles